Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment    

Global In Vitro Diagnostics Market Research Report

PRODUCT TITLE PUBLISHED
TEG/Thrombelastrography TEG/Thrombelastrography
TEG/Thrombelastrography and ROTEM/Rotational Thromboelastrometry and
Upcoming
ROTEM/Rotational Thromboelastrometry ROTEM/Rotational Thromboelastrometry
ROTEM/Rotational Thromboelastrometry and TEG/Thrombelastrography and
Upcoming
Sonoclot Sonoclot
Sonoclot and TEG/Thrombelastrography and
Upcoming
North American Clinical Chemistry North American Clinical Chemistry
The North American clinical chemistry market was estimated at $3,852.7 million in 2013 and is expected to reach $5,370.5 million by 2019, at a CAGR of 7.2% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Upcoming
European Clinical Chemistry European Clinical Chemistry
Although earlier, Europe showed a negative growth rate in the clinical chemistry market, in some countries revenues grew compared to 2011. Germany commanded the largest share (20%) at an estimated $652.8 million in 2013 and is expected to reach $853.3 million by 2018, at a CAGR of 5.8% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Upcoming
Europe Coagulation Europe Coagulation
Europe holds the second position in the global coagulation market after the Americas. Germany commanded the largest share (20%) at an estimated $186.9 million in 2013 and is expected to reach $231.1 million by 2018, at a CAGR of 4.5% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Upcoming
Asia-Pacific Clinical Chemistry Analyzer Asia-Pacific Clinical Chemistry Analyzer
The Asia-Pacific clinical chemistry market is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1047.2 million by 2018, at a CAGR of 16.0% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Mar 2015
Europe Reagents & Kits Europe Reagents & Kits
The major changes in this sector have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, the new technologies have enabled a better understanding of disease processes. The report “European IVD Reagents & Kits Market forecast for 2018 “analyzes the market by 2 segments such as general purpose Reagents & Kits and analyte specific Reagents & Kits.
Upcoming
Europe Instruments Europe Instruments
The major changes in this sector have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, the new technologies have enabled a better understanding of disease processes. The report “European IVD Instruments Market forecast for 2018 “analyzes the market by 3 segments such as high risk and risk devices, devices for self testing and other devices.  
Upcoming
North American Tissue Diagnostics North American Tissue Diagnostics
  The North American Tissue Diagnosis Devices Market, mainly driven by rapidly increasing incidence of cancer, value was estimated to be $1,228.14 million in 2013 and is expected to be $1,684.24 million by 2018, at a CAGR of 6.52% from 2013 to 2018. The market divided by 4 segments such as Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market. The major players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S.), and Bio SB (U.S.).
Upcoming
European Tissue Diagnostics Market European Tissue Diagnostics Market
The European Tissue Diagnosis Devices Market, mainly driven by rapidly increasing incidence of cancer, which was valued $868.49 million in 2013 and is expected to be $1136.70 million by 2018, at a CAGR of 5.53% from 2013 to 2018. The market divided by 4 segments such as Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market. The major players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S.), and Bio SB (U.S.).
Upcoming
BRIC Tissue Diagnostics BRIC Tissue Diagnostics
The BRIC Tissue Diagnosis Devices Market, mainly driven by rapidly increasing incidence of cancer, which was valued $264.75 million in 2013 and is expected to be $476.88 million by 2018, at a CAGR of 12.49% from 2013 to 2018. The market divided by 4 segments such as Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market. The major players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S.), and Bio SB (U.S.).
Upcoming
Europe Hematology Europe Hematology
Europe holds second largest market position after North America. Germany commanded the largest share 20% of the Europe hematology market at an estimated $272.8 million in 2013 and is expected to reach $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The report “European Hematology Market forecast for 2018 “analyzes the market by 2 segments such as hematology reagents and hematology instruments.
Upcoming
North America Hematology North America Hematology
North America commanded the largest share 41.75% of the Global hematology market at an estimated $1810.4 million in 2013 and are expected to reach $2479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. The report “North American Hematology Market forecast for 2018 “analyzes the market by 2 segments such as reagents and instruments.
Upcoming
Asia Hematology Asia Hematology
Asian Hematology market is growing in double digit and will continue to grow in future. China commanded the largest share 53% of Asian hematology market at an estimated $216.0 million in 2013 and is expected to reach $429.1 million by 2018, at a CAGR of 15.4% from 2013 to 2018. The report “Asian Hematology Market forecast for 2018 “analyzes the market by 2 segments such as reagents and instruments.
Upcoming
North America Coagulation North America Coagulation
The Americas commanded the largest share 42% of the Global Coagulation market at an estimated $1240.8 million in 2013 and are expected to reach $1638.7 million by 2018, at a CAGR of 6% from 2013 to 2018. The report “North American Coagulation Market forecast for 2018 “analyzes the market by two segments such as coagulation instruments and coagulation reagents.
Upcoming
Asia Coagulation Asia Coagulation
Asian Coagulation market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $148.0 million in 2013 and is expected to reach $283.6 million by 2018, at a CAGR of 14.6% from 2013 to 2018. The report “Asian Coagulation Market forecast for 2018 “analyzes the market by two segments such as coagulation instruments and coagulation reagents.
Upcoming
Europe Immunoassay Europe Immunoassay
Europe holds second largest market position in Global Immunoassay Market. Germany commanded the largest share 20% of the European immunoassay market at an estimated $790.6 million in 2013 and is expected to reach $1066.7 million by 2018, at a CAGR of 6.5% from 2013 to 2018. The report “European Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
Upcoming
Europe Microbiology Europe Microbiology
Next to America, Europe holds second largest market position. Germany commanded the largest share 20% at an estimated $223.7 million in 2013 and is expected to reach $272.5 million by 2018, at a CAGR of 4.2% from 2013 to 2018. The report “European Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents.
Upcoming
North America Immunoassay North America Immunoassay
The Americas commanded the largest share 42% of the Global Immunoassay market at an estimated $5248.2 million in 2013 and are expected to reach $7563.2 million by 2018, at a CAGR of 8% from 2013 to 2018. The report “North American Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
Upcoming
68 reports | Show
Connect With Us
US/CAN : +1-888-502-0539